Insights

A new device measures heart-carotid pulse wave velocity (hcPWV) as a reliable alternative to carotid-femoral PWV (cfPWV) for assessing arterial stiffness. This non-invasive method shows strong agreement with cfPWV, paving the way for easier monitoring.

Area of Science:

  • Cardiovascular Physiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Carotid-femoral pulse wave velocity (cfPWV) is a key indicator of aortic arterial stiffness and cardiovascular risk.
  • Current cfPWV measurement limitations include the need for femoral access, hindering routine clinical and self-monitoring applications.
  • Heart-carotid PWV (hcPWV) offers a potential non-invasive alternative for assessing aortic stiffness.

Purpose of the Study:

  • To introduce and evaluate a novel device for measuring hcPWV using phonocardiogram (PCG) and photoplethysmography (PPG) signals.
  • To assess the feasibility and reliability of in-vivo hcPWV measurements.
  • To examine the association and agreement between hcPWV and cfPWV.

Main Methods:

  • Simultaneous acquisition of PCG signals at the heart and PPG signals at the carotid artery.
  • Measurement of pulse transit time (PTT) between the heart and carotid artery.
  • Comparison of hcPWV with cfPWV using Pearson's correlation coefficient in 30 subjects.

Main Results:

  • The novel device demonstrated repeatable beat-to-beat PTT measurements with a coefficient of variation (CoV) below 12%.
  • Mean hcPWV was 4.67 ± 0.95 m/s, and mean cfPWV was 6.17 ± 1.17 m/s.
  • A strong positive correlation was found between hcPWV and cfPWV (r = 0.71, p <0.001), indicating good agreement.

Conclusions:

  • The novel hcPWV measurement shows promising reliability and strong agreement with the established cfPWV method.
  • This non-invasive approach has significant potential for assessing arterial stiffness in settings where cfPWV is difficult to obtain.
  • Further large-scale studies are needed to validate hcPWV, with future applications in wearable technology for homecare and ambulatory monitoring.